Larson PS - Search Results

1

Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.

Katz M, Luciano MS, Carlson K, Luo P, Marks WJ Jr, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL; CSP 468 study group. Katz M, et al. Among authors: larson ps. Ann Neurol. 2015 Apr;77(4):710-9. doi: 10.1002/ana.24374. Ann Neurol. 2015. PMID: 25627340 Clinical Trial.

2

Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome.

Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. Papavassiliou E, et al. Among authors: larson ps. Neurosurgery. 2004 May;54(5):1120-29; discussion 1129-30. doi: 10.1227/01.neu.0000119329.66931.9e. Neurosurgery. 2004. PMID: 15113466

3

Placement of deep brain stimulator electrodes using real-time high-field interventional magnetic resonance imaging.

Martin AJ, Larson PS, Ostrem JL, Keith Sootsman W, Talke P, Weber OM, Levesque N, Myers J, Starr PA. Martin AJ, et al. Among authors: larson ps. Magn Reson Med. 2005 Nov;54(5):1107-14. doi: 10.1002/mrm.20675. Magn Reson Med. 2005. PMID: 16206144 Free article. Clinical Trial.

4

Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series.

Larson PS, Richardson RM, Starr PA, Martin AJ. Larson PS, et al. Stereotact Funct Neurosurg. 2008;86(2):92-100. doi: 10.1159/000112430. Epub 2007 Dec 12. Stereotact Funct Neurosurg. 2008. PMID: 18073522

5

Deep brain stimulation for psychiatric disorders.

Larson PS. Larson PS. Neurotherapeutics. 2008 Jan;5(1):50-8. doi: 10.1016/j.nurt.2007.11.006. Neurotherapeutics. 2008. PMID: 18164483 Free PMC article. Review.

6

Deep brain stimulator hardware-related infections: incidence and management in a large series.

Sillay KA, Larson PS, Starr PA. Sillay KA, et al. Among authors: larson ps. Neurosurgery. 2008 Feb;62(2):360-6; discussion 366-7. doi: 10.1227/01.neu.0000316002.03765.33. Neurosurgery. 2008. PMID: 18382313

7

Minimally invasive precision brain access using prospective stereotaxy and a trajectory guide.

Martin AJ, Hall WA, Roark C, Starr PA, Larson PS, Truwit CL. Martin AJ, et al. Among authors: larson ps. J Magn Reson Imaging. 2008 Apr;27(4):737-43. doi: 10.1002/jmri.21318. J Magn Reson Imaging. 2008. PMID: 18383266

8

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT. Marks WJ Jr, et al. Among authors: larson ps. Lancet Neurol. 2008 May;7(5):400-8. doi: 10.1016/S1474-4422(08)70065-6. Epub 2008 Apr 2. Lancet Neurol. 2008. PMID: 18387850 Clinical Trial.

9

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.

Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ. Eberling JL, et al. Neurology. 2008 May 20;70(21):1980-3. doi: 10.1212/01.wnl.0000312381.29287.ff. Epub 2008 Apr 9. Neurology. 2008. PMID: 18401019 Clinical Trial.

10

Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome.

Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. Papavassiliou E, et al. Among authors: larson ps. Neurosurgery. 2008 Feb;62 Suppl 2:884-94. doi: 10.1227/01.neu.0000316290.83360.7e. Neurosurgery. 2008. PMID: 18596419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters